Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission: Significant Impact of the Interval Between Diagnosis and Transplantation on Different Outcomes
Stéphanie Ducreux, Valérie Dubois(Établissement Français du Sang), Fiorenza Barraco(Hôpital Lyon Sud), Mauricette Michallet(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Franck E. Nicolini(Université Claude Bernard Lyon 1), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Mohamad Sobh(Ottawa Hospital), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Marie Balsat(Hôpital Claude Huriez), Caroline Lejeune(Hôpital Lyon Sud), Stéphane Morisset(Lyon 1 Université)
Cited by 1
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547